`
`
`
`›
`
`
`
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00001
`
`/ About Us — Explore More
`OUR VISION
`Powering smarter healthcare for
`everyone, everywhere
`At IQVIA, we want to help ensure essential treatments reach
`all human beings all over the world, no matter where they are.
`To get there, we work with customers and partners to
`accelerate their results and address unmet needs.
`About
`JUMP TO
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00002
`
`OUR PEOPLE
`We are focused on driving
`healthcare forward, supported by
`four key principles
`Passion
`We strive to make a positive impact in
`everything we do.
`Innovation
`We approach every problem with
`curiosity and an open-mind to better
`support our customers’ innovations.
`Collaboration
`We aim to bring out
`other and our divers
`maximize our positiv
`working together.
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00003
`
`IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical
`research services to the life sciences industry. IQVIA creates intelligent connections across all
`aspects of healthcare through its analytics, transformative technology, big data resources and
`extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with
`speed and agility — enabling customers to accelerate the clinical development and
`commercialization of innovative medical treatments that improve healthcare outcomes for
`patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100
`countries.
`Explore More
`IQVIA Patient Experience Solutions powered by Apple
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00004
`
`Our Impact
`IQVIA Connected Intelligence
`Environmental, Social and Governance
`Commitment to Public Health
` Code of Conduct
`Innovation Hub
`Leadership
`Privacy
`Third Party Access Program
`You may also be interested in
`Featured Innovations
`The IQVIA Institute
`Insights Library
`
`
`Novo Nordisk Exhibit 2480
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00005
`
`Investor Relations
`Customer Portal
`Careers
`Code of Conduct
`Events
`Contact Us
`Third-Party Access
`Suppliers
`Privacy
`Your Privacy Choices
`Terms of Use
`Sitemap
`©2023 IQVIA Inc, All Rights Reserved.
`